Centre Hospitalier Universitaire de Limoges

The CHU Limoges is the owner of one of the 4 biobanks on which a large part of the project is built, and will be the sponsor of the BIOMARGIN European prospective cohort study.
The Department of Pharmacology-Toxicology (Head: Pierre Marquet) and the Department of Nephrology-Transplantation (Prof Marie Essig) at CHU Limoges will participate in the BioMargin project.
Contact persons active in BioMargin
Prof Pierre Marquet
Prof Marie Essig